Pillstats
Rx only · Solution · Oral

Hydromorphone Hydrochloride

Brands: Dilaudid · Hydromorphone Hydrochloride

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3423
US makers4 labelers
Packages5
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.083$0.165$0.248$0.330Dec 2025Apr 2026Jul 2026
$0.238
Latest avg · Jul 22, 2026
-17%
Since Dec 17, 2025
4
Active US suppliers
60%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3647291.1K1.5K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.1K
Rx · 2026 Q1
279K
Units dispensed
+10%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Rhodes Pharmaceuticals LLCunknown2SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING
Ascent Pharmaceuticals, Inc.unknown1SUPPLYING
American Health Packagingunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.